Camille L. Bedrosian
Amplyx Pharmaceuticals (United States)
ORCID: 0009-0005-9213-4982Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Top 100%percentile
Indexed papers
0in pilot corpus
Papers
Driven by 2 papers. Top paper: “Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program”.
15 citations
Gregory M. Enns, Antonio Nino Ramirez, Camille L. Bedrosian, Bridget Reineking, Xiaoxiao Lu +4 more
0 citations
Eric S. Kawaguchi, Li Ding, Graeme Rosenberg, Takashi Harano, Sean C. Wightman +5 more